Literature DB >> 12827312

Effect of increased (99m)Tc/(99)Tc ratios on count rates in sentinel node procedures: a randomised study.

G M M Gommans1, F M van der Zant, T G van der Schors, A van Dongen, G J J Teule, W W J Clarijs, B L A M Langenhorst, J W D de Waard.   

Abstract

The aim of this study was to evaluate the count rates of sentinel lymph nodes (SLNs) in patients with breast cancer in the operating theatre, using (99m)Tc-Nanocoll with different ratios of technetium-99m to technetium-99. After written informed consent had been obtained, we tested different ratios of (99m)Tc/(99)Tc-Nanocoll in a double-blinded randomised study performed in 161 patients. Twenty-five MBq/ microg (99m)Tc-colloid albumin was prepared in vacuum. In 87 patients (group A) a 2-h elution was used and in 74 patients (group B) a 24-h elution was used. Patients were subcategorised into subgroups 1 and 3, in which an SLN procedure for breast carcinoma was performed simultaneously with lumpectomy, and subgroups 2 and 4, in which an SLN procedure was performed 2-3 weeks after prior excision biopsy. All patients were injected along the lateral border of the areola (two injections: 50 MBq/0.3 ml intradermally and 50 MBq/2 ml intraparenchymally). Ex vivo measurement of count rates was performed with a gamma probe. Comparing groups A and B in respect of registered counts per second (cps) of excised SLNs, a significant difference was found ( P<0.004). When comparisons were made between subgroups 1 and 2 (2-h elution) and between subgroups 3 and 4 (24-h elution) in respect of registered cps of excised SLNs, no significant difference was found (subgroup 1 vs 2, P=0.825; subgroup 3 vs 4, P=0.915). Use of a 2-h elution in vacuum yielded a significantly higher count rate of maximum specific activity of (99m)Tc-colloid albumin in SLNs than was achieved using a 24-h elution in vacuum. SLN procedures performed 2-3 weeks after prior excision biopsy proved reliable as compared to SLN procedures performed simultaneously with lumpectomy.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12827312     DOI: 10.1007/s00259-003-1227-9

Source DB:  PubMed          Journal:  Eur J Nucl Med Mol Imaging        ISSN: 1619-7070            Impact factor:   9.236


  23 in total

Review 1.  Vital dyes in sentinel node localization.

Authors:  P J Bostick; A E Giuliano
Journal:  Semin Nucl Med       Date:  2000-01       Impact factor: 4.446

2.  Unfiltered sulfur colloid and sentinel node biopsy for breast cancer: technical and kinetic considerations.

Authors:  F L Moffat; S A Gulec; S Y Sittler; A N Serafini; G N Sfakianakis; J E Boggs; D Franceschi; C S Pruett; R Pop; C Gurkok; A S Livingstone; D N Krag
Journal:  Ann Surg Oncol       Date:  1999-12       Impact factor: 5.344

3.  Factors affecting sentinel node localization during preoperative breast lymphoscintigraphy.

Authors:  P I Haigh; N M Hansen; A E Giuliano; G K Edwards; W Ye; E C Glass
Journal:  J Nucl Med       Date:  2000-10       Impact factor: 10.057

4.  The hidden sentinel node in breast cancer.

Authors:  P J Tanis; J W van Sandick; O E Nieweg; R A Valdés Olmos; E J T Rutgers; C A Hoefnagel; B B R Kroon
Journal:  Eur J Nucl Med Mol Imaging       Date:  2002-03       Impact factor: 9.236

5.  Mammary lymphoscintigraphy with various radiopharmaceuticals in breast cancer.

Authors:  S Imoto; K Murakami; H Ikeda; H Fukukita; N Moriyama
Journal:  Ann Nucl Med       Date:  1999-10       Impact factor: 2.668

6.  Sentinel node biopsy in 70 unselected patients with breast cancer: increased feasibility by using 10 mCi radiocolloid in combination with a blue dye tracer.

Authors:  F W van der Ent; R A Kengen; H A van der Pol; A G Hoofwijk
Journal:  Eur J Surg Oncol       Date:  1999-02       Impact factor: 4.424

7.  Effect of high specific-activity sulfur colloid preparations on sentinel node count rates.

Authors:  Borys R Krynyckyi; Zhuang-Yu Zhang; Chun K Kim; Helena Lipszyc; Karina Mosci; Josef Machac
Journal:  Clin Nucl Med       Date:  2002-02       Impact factor: 7.794

Review 8.  Radioguided sentinel lymph node biopsy in breast cancer surgery.

Authors:  G Mariani; L Moresco; G Viale; G Villa; M Bagnasco; G Canavese; J Buscombe; H W Strauss; G Paganelli
Journal:  J Nucl Med       Date:  2001-08       Impact factor: 10.057

9.  In vivo evaluation of three different 99mTc-labelled radiopharmaceuticals for sentinel lymph node identification.

Authors:  M M Edreira; L L Colombo; J H Perez; E O Sajaroff; S G de Castiglia
Journal:  Nucl Med Commun       Date:  2001-05       Impact factor: 1.690

10.  Improved sentinel node visualization in breast cancer by optimizing the colloid particle concentration and tracer dosage.

Authors:  R A Valdés Olmos; P J Tanis; C A Hoefnagel; O E Nieweg; S H Muller; E J Rutgers; M L Kooi; B B Kroon
Journal:  Nucl Med Commun       Date:  2001-05       Impact factor: 1.690

View more
  1 in total

1.  Effect of increased 99mTc/99Tc ratios on count rates in sentinel node procedures: a randomised study.

Authors:  James R Ballinger
Journal:  Eur J Nucl Med Mol Imaging       Date:  2004-02       Impact factor: 9.236

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.